Last question in that interview:Lauren Evans: And is there...

  1. neg
    3,781 Posts.
    lightbulb Created with Sketch. 173
    Last question in that interview:

    Lauren Evans:
    And is there anything else that you'd like to add, James?

    James Bonnar: One more thing, Lauren. In the study, we also ran an exploratory arm with a new compound we're developing, and we saw a really good reduction in cholesterol in the first 14 days. So, we're going to work on that compound as a potential backup or second-generation compound in parallel with putting NYX-PCSK9i through preclinical testing.

    $50 mill market Cap, Directors loading up plus their Brian Injury Program.
    Still have a little overhang from recent Cap raise but excellent opportunity at these prices!

    Market definitely asleep on this one IMO!


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
37.0¢
Change
0.015(4.23%)
Mkt cap ! $78.03M
Open High Low Value Volume
36.5¢ 37.0¢ 36.0¢ $244.1K 667.9K

Buyers (Bids)

No. Vol. Price($)
1 4705 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 597241 3
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.